These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND SEPT9, PNUTL4, 10801, ENSG00000184640, MSF1, KIAA0991, AF17q25, MSF, SeptD1, SINT1 AND Treatment
16 results:

  • 1. Circulating-tumour DNA methylation of HAND1 gene: a promising biomarker in early detection of colorectal cancer.
    Shavali M; Moradi A; Tahmaseb M; Mohammadian K; Ganji SM
    BMC Med Genomics; 2024 Apr; 17(1):117. PubMed ID: 38689296
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer.
    Müller D; Győrffy B
    Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188722. PubMed ID: 35307512
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Application of droplet digital polymerase chain reaction of plasma methylated septin 9 on detection and early monitoring of colorectal cancer.
    Ma ZY; Chan CSY; Lau KS; Ng L; Cheng YY; Leung WK
    Sci Rep; 2021 Dec; 11(1):23446. PubMed ID: 34873218
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. msept9 Can Monitor the Response and Predict the Prognosis of Stage IV colorectal cancer Patients with Liver Metastasis Undergoing Potentially Curative Surgery.
    Liu W; Hu P; Liu J; Chen L
    J Surg Res; 2021 Nov; 267():485-494. PubMed ID: 34246842
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Relationship of DNMT3b expression and sept9 methylation in theprogression of colorectal carcinogenesis].
    He N; Feng G; Dou JH; Tang GB; Qian MR; Chen L; Wu KC
    Zhonghua Zhong Liu Za Zhi; 2020 Nov; 42(11):925-930. PubMed ID: 33256303
    [No Abstract]    [Full Text] [Related]  

  • 6. Detection of Methylated sept9 in Korean colorectal cancer Patients: Comparison with Previous Studies.
    Kim H; Lee JK; Hong YJ; Moon SM; Shin US; Kwon H; Shin K; Chang YH
    Clin Lab; 2018 Sep; 64(9):1573-1579. PubMed ID: 30273999
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for colorectal cancer Liver Metastasis.
    Bhangu JS; Beer A; Mittlböck M; Tamandl D; Pulverer W; Schönthaler S; Taghizadeh H; Stremitzer S; Kaczirek K; Gruenberger T; Gnant M; Bergmann M; Mannhalter C; Weinhäusel A; Oehler R; Bachleitner-Hofmann T
    Ann Surg; 2018 Nov; 268(5):894-902. PubMed ID: 30080722
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Potential of quantitative sept9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study.
    Bergheim J; Semaan A; Gevensleben H; Groening S; Knoblich A; Dietrich J; Weber J; Kalff JC; Bootz F; Kristiansen G; Dietrich D
    Br J Cancer; 2018 May; 118(9):1217-1228. PubMed ID: 29610456
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study.
    Schröck A; Leisse A; de Vos L; Gevensleben H; Dröge F; Franzen A; Wachendörfer M; Schröck F; Ellinger J; Teschke M; Wilhelm-Buchstab T; Landsberg J; Holdenrieder S; Hartmann G; Field JK; Bootz F; Kristiansen G; Dietrich D
    Clin Chem; 2017 Jul; 63(7):1288-1296. PubMed ID: 28515105
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. DNA methylation based biomarkers in colorectal cancer: A systematic review.
    Lam K; Pan K; Linnekamp JF; Medema JP; Kandimalla R
    Biochim Biophys Acta; 2016 Aug; 1866(1):106-20. PubMed ID: 27385266
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Detection of colorectal cancer by DNA methylation biomarker sept9: past, present and future.
    Li Y; Song L; Gong Y; He B
    Biomark Med; 2014; 8(5):755-69. PubMed ID: 25123042
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A panel of genes methylated with high frequency in colorectal cancer.
    Mitchell SM; Ross JP; Drew HR; Ho T; Brown GS; Saunders NF; Duesing KR; Buckley MJ; Dunne R; Beetson I; Rand KN; McEvoy A; Thomas ML; Baker RT; Wattchow DA; Young GP; Lockett TJ; Pedersen SK; Lapointe LC; Molloy PL
    BMC Cancer; 2014 Jan; 14():54. PubMed ID: 24485021
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [The new blood test bio-marker sept9 and colorectal carcinoma screening].
    Beneš Z; Sedivcová M; Antoš Z; Kohout P; Puškárová G; Cerník M; Rozmahel M; Shánělová M; Dolina J; Hep A; Trubač M; Stehlík J; Vaněček T; Michal M; Simša J; Kala Z
    Vnitr Lek; 2013 Nov; 59(11):971-6. PubMed ID: 24279440
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Detection of methylated sept9 in plasma is a reliable screening method for both left- and right-sided colon cancers.
    Tóth K; Sipos F; Kalmár A; Patai AV; Wichmann B; Stoehr R; Golcher H; Schellerer V; Tulassay Z; Molnár B
    PLoS One; 2012; 7(9):e46000. PubMed ID: 23049919
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Hypermethylation of the CDH1, sept9, HLTF and ALX4 genes and their diagnostic significance in colorectal cancer].
    Kostin PA; Zakharzhevskaia NB; Generozov EV; Govorun VM; Chernyshov SV; Shchelygin IuA
    Vopr Onkol; 2010; 56(2):162-8. PubMed ID: 20552891
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Recent patents and advances in genomic biomarker discovery for colorectal cancers.
    Quyun C; Ye Z; Lin SC; Lin B
    Recent Pat DNA Gene Seq; 2010 Jun; 4(2):86-93. PubMed ID: 20426761
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.